Next Century Growth Investors’s Cardlytics CDLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-8,655
Closed -$2.17M 134
2018
Q3
$2.17M Buy
+8,655
New +$1.86M 0.25% 110

Other funds holding CDLX

Next Century Growth Investors's CDLX Position: Q4 2018 in Review

Next Century Growth Investors sold out of Cardlytics (CDLX) in Q4 2018, closing a stake of 8,655 shares — an estimated $2.17M sold.

Next Century Growth Investors first reported a position in CDLX in Q3 2018 and held it in 1 quarter. The position peaked at $2.17M in Q3 2018. 61 funds tracked by Wall St. Rank hold CDLX as of Q4 2018.

  • Next Century Growth Investors reported no remaining Cardlytics position as of Q4 2018 after selling out during the quarter.
  • Next Century Growth Investors sold 8,655 Cardlytics shares in Q4 2018, an estimated $2.17M.
  • Next Century Growth Investors first reported a position in Cardlytics in Q3 2018 and held it in 1 quarter.
  • Next Century Growth Investors's Cardlytics position peaked at $2.17M in Q3 2018.
  • 61 funds tracked by Wall St. Rank held Cardlytics as of Q4 2018.

Based on Next Century Growth Investors's 13F filing for Q4 2018, filed 14 Feb 2019.